Huaren Pharmaceutical Co (SZSE:300110) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SZSE:300110 Huaren Pharmaceutical Co Ltd SZSE:300110
55 GF Score
Price ¥2.90
GF Value ¥3.13
Valuation Fairly Valued
! 8 Warning Signs
View Full Analysis

What is Huaren Pharmaceutical Co FFO?

FFO (Funds from operations) only applies to REITs.

SZSE:300110
55GF Score
Huaren Pharmaceutical Co Ltd SZSE:300110
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Huaren Pharmaceutical Co (SZSE:300110) Overvalued in 2026?

Based on GuruFocus' analysis, Huaren Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥2.90 is trading 7.3% below its estimated GF Value™ of ¥3.13. GuruFocus considers Huaren Pharmaceutical Co to be Fairly Valued.

Key valuation signals for SZSE:300110:

  • FFO:
  • GF Value™: ¥3.13 vs. price of ¥2.90 (7.3% below fair value)
  • GF Score™: 55/100 with 8 warning signs

No single metric tells the full story. See the SZSE:300110 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Huaren Pharmaceutical Co Business Description

Address No. 187 Zhuzhou Road, Qingdao, Shandong, CHN, 266100
Huaren Pharmaceutical Co Ltd is a China-based company engaged in the manufacture, and sale of non-polyvinyl chloride and Non-PVC large capacity preparations. Its categories of products include conventional infusion, therapy infusion, and nutrition infusion. The company distributes its products in domestic market, with Northeast China as its main market.
55GF Score

Get the complete analysis for SZSE:300110

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥2.90
Price
¥3.13
GF Value